Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining the Feasibility of Delivering VergeRx to Smokers Through Pharmacies in Federally Qualified Health Centers Regardless of Readiness to Quit

NCT06161675 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT06161675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06161675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining the Feasibility of Delivering VergeRx to Smokers Through Pharmacies in Federally Qualified Health Centers Regardless of Readiness to Quit
Lead sponsor
University of Virginia
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 23, 2024
Completion date
July 1, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tobacco use cessation